Page last updated: 2024-11-04

sibutramine and Drop Attack

sibutramine has been researched along with Drop Attack in 2 studies

sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride

Research Excerpts

ExcerptRelevanceReference
"Other IMMP case reports suggesting arrhythmias associated with sibutramine were assessed and further reports were obtained from the World Health Organisation (WHO) adverse drug reactions database."1.33QT interval prolongation associated with sibutramine treatment. ( Clark, DW; Harrison-Woolrych, M; Hill, GR; Rees, MI; Skinner, JR, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harrison-Woolrych, M1
Clark, DW1
Hill, GR1
Rees, MI1
Skinner, JR1
Schroeder, C1
Birkenfeld, AL1
Mayer, AF1
Tank, J1
Diedrich, A1
Luft, FC1
Jordan, J1

Trials

1 trial available for sibutramine and Drop Attack

ArticleYear
Norepinephrine transporter inhibition prevents tilt-induced pre-syncope.
    Journal of the American College of Cardiology, 2006, Aug-01, Volume: 48, Issue:3

    Topics: Blood Pressure; Cross-Over Studies; Cyclobutanes; Double-Blind Method; Head-Down Tilt; Heart Rate; H

2006

Other Studies

1 other study available for sibutramine and Drop Attack

ArticleYear
QT interval prolongation associated with sibutramine treatment.
    British journal of clinical pharmacology, 2006, Volume: 61, Issue:4

    Topics: Adult; Amino Acid Substitution; Appetite Depressants; Arrhythmias, Cardiac; Cyclobutanes; Electrocar

2006